The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.
Launched by SIEMENS HEALTHCARE A/S · Oct 29, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of medical imaging system called the PET-MR scanner. This machine combines two types of scans—PET (which helps look at how organs and tissues are functioning) and MRI (which gives detailed pictures of the body's structure). The goal of the trial is to see how well this new scanner works in a clinical setting, especially in terms of the quality of the images it produces and how quickly the scans can be done. By evaluating this new technology, the researchers hope to improve the scanning process and make it more comfortable for patients.
To participate in this trial, you need to be an adult who is scheduled for a PET-MR or PET-CT scan. You must also be able to provide written consent, meaning you agree to take part and understand what it involves. However, some people cannot join, such as those with certain metal implants, pacemakers, or if they are pregnant. If you do take part, you will go through the PET-MR scan, and the study will aim to gather information to enhance the quality and efficiency of future scans. Your participation could help improve medical imaging for many patients in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult test subjects for whom a PET-MR examination is indicated and will be performed, or
- • Test subjects for whom a PET-CT examination is indicated and will be performed
- • Test subjects of legal age who have given their written informed consent to participate in the clinical investigation
- • Written consent of the test subject to be informed in the event of suspected clinically relevant incidental findings
- • Written consent to the disclosure of a clinically relevant incidental finding to a subsequent physician (release from the duty of confidentiality)
- • The test subject´s written consent that the recorded image data may be made available to Siemens Healthcare A/S in pseudonymized form
- • Test subjects whose weight does not exceed the permissible weight limit of the patient table (200 kg).
- Exclusion Criteria:
- • Metal in and on the body that causes stress to the test subject during an examination in the FoV of the combined PET-MR system
- • All pacemakers and other implants
- • Pregnancy: The exclusion of test subjects of childbearing potential is carried out based on a positive pregnancy test
- • Test subjects who indicate an increased sensitivity to loud noises
- • Test subjects who are incapable of giving consent.
About Siemens Healthcare A/S
Siemens Healthcare A/S is a leading global provider of innovative medical technology and services, dedicated to enhancing patient care through advanced diagnostic and therapeutic solutions. With a strong emphasis on research and development, Siemens Healthcare A/S is at the forefront of medical imaging, laboratory diagnostics, and healthcare IT, striving to improve clinical outcomes and operational efficiency in healthcare settings. The company actively sponsors clinical trials to evaluate the efficacy and safety of its cutting-edge technologies, demonstrating a commitment to evidence-based medicine and collaboration with healthcare professionals worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported